Search results for "Leukemia L1210"

showing 10 items of 11 documents

Photolysis of N-hydroxpyridinethiones: a new source of hydroxyl radicals for the direct damage of cell-free and cellular DNA.

1996

N-Hydroxypyridine-2-thione (2-HPT), known to release hydroxyl radicals on irradiation with visible light, and two related compounds, viz. N-hydroxypyridine-4-thione (4-HPT) and N-hydroxyacridine-9-thione (HAT), were tested for their potency to induce DNA damage in L1210 mouse leukemia cells and in isolated DNA from bacteriophage PM2. DNA single-strand breaks and modifications sensitive to various repair endonucleases (Fpg protein, endonuclease III, exonuclease III, T4 endonuclease V) were quantified. Illumination of cell-free DNA in the presence of 2-HPT and 4-HPT gave rise to damage profiles characteristic for hydroxyl radicals, i.e. single-strand breaks and the various endonuclease-sensit…

LightDNA damageCell SurvivalPyridinesRadicalFree radical damage to DNABiologychemistry.chemical_compoundEndonucleaseMiceSuperoxidesGeneticsTumor Cells CulturedAnimalsBacteriophagesLeukemia L1210chemistry.chemical_classificationExonuclease IIIReactive oxygen speciesEndodeoxyribonucleasesPhotolysisSinglet OxygenHydroxyl RadicalThionesDNAOxygenBiochemistrychemistryBiophysicsbiology.proteinAcridinesHydroxyl radicalReactive Oxygen SpeciesDNAResearch ArticleDNA Damage
researchProduct

ChemInform Abstract: An Efficient Method for the Preparation of Antitumoral α-Keto-imines Benzyldihydroisoquinolines by Selective Benzylic Oxidation …

2010

A series of potent antitumor α-keto-imine BDHIQ derivatives were synthesized and assayed in vitro against L1210 leukemia cell line. A new and easy method for the direct formation of α-keto-imine from imine BDHIQ's was performed with 10% C/Pd in acetonitrile.

chemistry.chemical_compoundChemistryImineOrganic chemistryGeneral MedicineLeukemia L1210AcetonitrileCombinatorial chemistryIn vitroChemInform
researchProduct

Semisynthesis and cytotoxicity of styryl-lactone derivatives.

1999

The cytotoxicity and the cell-cycle action of altholactone (1), goniofufurone (2), and eight altholactone derivatives (5-12), were determined in vitro on L-1210 cells. Semisyntheses and structure-activity relationships of these compounds are described. The results of this study suggest that the cytotoxicity of altholactone (1), 11-nitro-altholactone (8), and 7-chloro-6,7-dihydroaltholactone (10) is due to the accumulation of the cells in the G2 + M phase of the cell cycle.

StereochemistryNitro compoundMolecular ConformationPharmaceutical ScienceChemical synthesisAnalytical ChemistryLactonesMiceDrug DiscoveryTumor Cells CulturedAnimalsCytotoxicityLeukemia L1210Pharmacologychemistry.chemical_classificationNew GuineaPlants MedicinalBicyclic moleculeChemistryOrganic ChemistrySemisynthesisAntineoplastic Agents PhytogenicIn vitroComplementary and alternative medicineCell cultureMolecular MedicineDrug Screening Assays AntitumorLactoneJournal of natural products
researchProduct

The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.

1989

The therapeutic efficacy of 5-fluorouracil (FUra) and cis-dichlorodiamine-platinum (cis-DDP) in mice bearing transplantable leukemia and solid tumors was evaluated using different sequences of combination of these agents. The optimal sequence was cis-DDP administered 24 h after FUra. The administration of FUra at its maximally tolerated dose (MTD) followed 24 h later by low doses of cis-DDP yielded less toxicity and higher response rate against L1210 and colon 26 than the administration of these two agents in the opposite sequence or concurrently at the MTD. The sequence of administration of these two agents was not therapeutically important when the antitumor activity was evaluated against…

DrugCancer Researchendocrine system diseasesLymphomaRatónmedicine.medical_treatmentmedia_common.quotation_subjectPharmacologyThymidylate synthaseDrug Administration ScheduleMiceAntineoplastic Combined Chemotherapy ProtocolsmedicineTumor Cells CulturedAnimalsLeukemia L1210media_commonPharmacologyChemotherapybiologyDose-Response Relationship Drugbusiness.industryThymidylate SynthaseDrug interactionmedicine.diseaseLeukemiaFluorouracilMice Inbred DBAToxicityImmunologyColonic Neoplasmsbiology.proteinFluorouracilCisplatinbusinessmedicine.drugSelective cancer therapeutics
researchProduct

Clavines as antitumor agents. 3: Cytostatic activity and structure/activity relationships of 1-alkyl agroclavines and 6-alkyl 6-noragroclavines.

1986

The cytostatic potential of twenty antibiotic agroclavines has been examined in the L5178y mouse lymphoma cell system. Twelve of these compounds are described for the first time. It is shown that the substituent at N-1 of agroclavine is very important whereas the substituent at N-6 is of less influence if it is not hydrogen. Incorporation studies in the presence of 1-propylagroclavine suggest that DNA synthesis in the lymphoma cells is inhibited. The effect on the corresponding [3H]thymidine incorporation in murine spleen lymphocytes is comparably low. Neither a significant change of mRNA efflux nor of DNA polymerase alpha and beta activities was caused. The mechanism of action seems to be …

MaleDNA polymeraseDNA-Directed DNA PolymeraseLymphocyte ActivationReceptors DopamineMiceStructure-Activity RelationshipDrug DiscoverymedicineAnimalsRNA MessengerRNA NeoplasmErgolinesLeukemia L1210ReceptorAlkylPharmacologychemistry.chemical_classificationAntibiotics AntineoplasticDNA synthesisbiologyDNA NeoplasmIn vitroNeoplasm ProteinsErgolineMechanism of actionchemistryBiochemistryReceptors Serotoninbiology.proteinEffluxmedicine.symptommedicine.drugThe Journal of Antibiotics
researchProduct

Synthesis and antileukemic activity of new 3-(1-phenyl-3-methylpyrazol-5-yl)-2-styrylquinazolin-4(3H)-ones.

2004

Abstract 3-(1-Phenyl-3-methylpyrazol-5-yl)-2-styrylquinazolin-4(3H)-ones 14a–q and 15a–q were synthesized by refluxing in acetic acid the corresponding 2-methylquinazolinones 12 and 13 with the opportune benzoic aldehyde for 12 h. The synthesized styrylquinazolinones 14a–q and 15a–q were tested in vitro for their antileukemic activity against L1210 (murine leukemia), K562 (human chronic myelogenous leukemia) and HL60 (human leukemia) cell lines showing in some cases good activity.

Magnetic Resonance SpectroscopyStereochemistryHL60Pharmaceutical ScienceAntineoplastic AgentsHL-60 CellsAcetic acidchemistry.chemical_compoundStructure-Activity RelationshipDogshemic and lymphatic diseasesDrug Discoverymedicine3-(1-Phenyl-3-methylpyrazol-5-yl)-2-styrylquinazolin-4(3H)-oneAnimalsHumansLeukemia L1210LeukemiaGeneral Medicinemedicine.diseaseMolecular biologySettore CHIM/08 - Chimica FarmaceuticaIn vitroLeukemiachemistryCell cultureAntileukemic activityQuinazolinesIndicators and ReagentsBenzoic AldehydeK562 CellsCell DivisionChronic myelogenous leukemiaK562 cellsFarmaco (Societa chimica italiana : 1989)
researchProduct

Synthesis and Antileukemic Activity of New 3-(5-Methylisoxazol-3-yl) and 3-(Pyrimidin-2-yl)-2-styrylquinazolin-4(3H)-ones.

2003

3-(3-Methylisoxazol-5-yl) and 3-(pyrimidin-2-yl)-2-styrylquinazolin-4(3H)-ones 8a–l and 9a,c–e,h–l were synthesized by refluxing in acetic acid the corresponding 2-methylquinazolinones 6 and 8 with the opportune benzoic aldehyde for 12 h. The synthesized styrylquinazolinones 8a–l and 9a,c–e,h–l were tested in vitro for their antileukemic activity against L-1210 (murine leukemia), K-562 (human chronic myelogenous leukemia) and HL-60 (human leukemia) cell lines showing in some cases good activity.

Human leukemiaStereochemistryDrug Evaluation PreclinicalPharmaceutical ScienceAntineoplastic AgentsHL-60 Cells3-(3-Methylisoxazol-5-yl)-2-styrylquinazolin-4(3H)-ones 3-(Pyrimidin-2-yl)-2-styrylquinazolin-4(3H)-ones Antileukemic activitySettore BIO/19 - Microbiologia GeneraleAcetic acidchemistry.chemical_compoundDrug DiscoverymedicineColchicineAnimalsHumansLeukemia L1210OxazolesCzech RepublicMolecular StructureChemistryGeneral Medicinemedicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaIn vitroLeukemiaCell cultureQuinazolinesColchicineK562 CellsBenzoic AldehydeK562 cellsChronic myelogenous leukemiaChemInform
researchProduct

Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.

1984

The L1210 tumor system was used in vitro and in vivo in comparative studies with activated cyclophosphamide analogs, cyclophosphamide and phosphoramide mustard. All the above compounds gave substantial cell kills (5 logs) of L1210 in vivo at doses that were non-toxic, but slight differences were noted. ASTA Z 7557 had a slight advantage in cure rate over cyclophosphamide when these drugs were given i.v. or i.p. to early tumor (i.p.). However, cyclophosphamide had the advantage in cure rate when drug administration was i.v. to advanced tumor. At equimolar concentrations in vitro ASTA Z 7557 was more cytotoxic than either phosphoramide mustard or acrolein. In vivo, the activated cyclophospham…

CyclophosphamideCell SurvivalPharmacologychemistry.chemical_compoundMiceFibrosisIn vivomedicineAnimalsPharmacology (medical)Clonogenic assayLeukemia L1210CyclophosphamideTumor Stem Cell AssayPharmacologyMice Inbred BALB CDose-Response Relationship Drugbusiness.industryAcroleinTumor Stem Cell Assaymedicine.diseasePhosphoramide MustardIn vitroOncologychemistryMice Inbred DBAPhosphoramide Mustardsbusinessmedicine.drugInvestigational new drugs
researchProduct

Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovaria…

1994

The effects of E-64 (Cathepsin B and L inhibitor) and Pepstatin A (Cathepsin D inhibitor) on spontaneous and experimental metastasis formation were investigated in mice with MCa mammary carcinoma, M5076 ovarian sarcoma and L1210 leukemia. Pepstatin induced a marked decrease in the number of spontaneous metastasis in MCa or M5076 tumor bearing mice. This phenomenon was also noted with E-64 but only in M5076 tumor bearing mice. On the other hand, both these agents were unable to prevent the formation of experimental metastasis in mice injected i.v. with L1210, MCa or M5076 tumor cells or with tumor cells in which Cathepsin B, L and D activities were inhibited by a 24 hour continuous exposure …

Ovarian NeoplasmsCathepsin LMammary Neoplasms ExperimentalpepstatinCysteine Proteinase Inhibitorsproteinase inhibitors.Cathepsin DCathepsinsCathepsinCathepsin BCysteine EndopeptidasesMiceLeucineEndopeptidasesPepstatinsTumor Cells CulturedAnimalsmetastasiFemaleNeoplasm MetastasisLeukemia L1210E-64In vivo (Athens, Greece)
researchProduct

An efficient method for the preparation of antitumoral α-keto-imines benzyldihydroisoquinolines by selective benzylic oxidation with C/Pd in acetonit…

2002

A series of potent antitumor α-keto-imine BDHIQ derivatives were synthesized and assayed in vitro against L1210 leukemia cell line. A new and easy method for the direct formation of α-keto-imine from imine BDHIQ's was performed with 10% C/Pd in acetonitrile.

chemistry.chemical_compoundchemistryCell cultureOrganic ChemistryDrug DiscoveryImineLeukemia L1210AcetonitrileBiochemistryMedicinal chemistryIn vitroTetrahedron Letters
researchProduct